US-listed company Basel Medical Group has suspended its Bitcoin acquisition strategy
According to ChainCatcher, as reported by Cointelegraph, US-listed company Basel Medical Group Ltd announced today that it has suspended its Bitcoin acquisition strategy, citing ongoing regulatory uncertainty surrounding digital assets in the United States.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Semiconductor sector in turmoil: profit realization and financing outcomes will be key
JPMorgan facilitates oil product transactions between Syria and Saudi Arabia.
Mauna Kea Technologies Publishes Q3 and Nine-Month 2026 Sales Presentation
BUZZ - Crude oil prices decline, cruise line stocks soar
Crypto prices
More
